Aktie A2PEJ7 STEALTH BIOTHERAPEUTICS CORP
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Stealth BioTherapeutics Corp

Aktien

A2PEJ7

US85789A1051

MITO

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Stealth BioTherapeutics Corp Highlights Opportunities and Challenges in Ultra-Rare Disease Drug Development at World Orphan Drug Congress USA
Stealth BioTherapeutics Announces Positive End-Of-Phase 2 Meeting with FDA on the Development of Elamipretide in Patients with Dry Age-related Macular Degeneration
Stealth Biotherapeutics Enters into Exclusive Licensing Agreement with Pharmanovia to Commercialize Elamipretide
Stealth BioTherapeutics Corp Announces Completion of Merger
Stealth BioTherapeutics Corp(NasdaqGM:MITO) dropped from NASDAQ Composite Index
J. Wood Capital Advisors LLC and Morningside Venture (I) Investments Limited completed the acquisition of 22.5293% stake in Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Stealth BioTherapeutics Corp Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis
Stealth BioTherapeutics : Investor Presentation - October 2022
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
Stealth BioTherapeutics Announces Departure of Chief Financial Officer
Stealth BioTherapeutics Chief Financial Officer Departs
Stealth BioTherapeutics Announces Departure of Chief Financial Officer
Stealth BioTherapeutics Corp Announces Departure of Robert Weiskopf as Chief Financial Officer
Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events
Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction
Stealth BioTherapeutics Corp Agrees to Go Private; Shares Jump
Stealth BioTherapeutics : Enters Definitive Agreement for Going Private Transaction - Form 6-K
STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQ
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PEJ7 Aktie
  4. Nachrichten Stealth BioTherapeutics Corp
  5. Andere Sprachen